This HTML5 document contains 204 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
n12http://dx.doi.org/10.1007/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n11https://scigraph.springernature.com/pub.10.1007/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q50990782
rdf:type
wikibase:Item
schema:description
vetenskaplig artikel naučni članak vědecký článek наукова стаття, опублікована в листопаді 2011 2011年学术文章 научни чланак artículo científico publicado en 2011 2011年學術文章 artykuł naukowy artikel ilmiah 2011년 논문 scientific article published on 25 November 2011 บทความทางวิทยาศาสตร์ article scientifique 2011 നവംബര്‍ 25 നു പ്രസിദ്ധീകരിച്ച ശാസ്ത്ര ലേഖനം مقالة علمية نشرت في 25 نوفمبر 2011 2011年学术文章 bilimsel makale tieteellinen artikkeli 2011年学术文章 articol științific სამეცნიერო სტატია artigo científico videnskabelig artikel scienca artikolo scientific article published on 25 November 2011 мақолаи илмӣ artikull shkencor 2011 nî lūn-bûn επιστημονικό άρθρο научна статия 2011年學術文章 wetenschappelijk artikel artículu científicu vedecký článok articolo scientifico מאמר מדעי scientific article published on 25 November 2011 artigo científico article scientific 2011年學術文章 2011年学术文章 bài báo khoa học ২৫ নভেম্বর ২০১১-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ artigo científico teaduslik artikkel article científic vitenskapelig artikkel 2011年學術文章 2011年學術文章 wissenschaftlicher Artikel artikulong pang-agham vitskapeleg artikkel научная статья научни чланак 2011年学术文章 tudományos cikk 2011年の論文 2011年学术文章
p:P577
wds:Q50990782-AE8D076B-CA82-4A02-8687-8F4287C9822D
wdt:P577
2011-11-25T00:00:00Z
p:P2888
wds:Q50990782-1F5CBE19-AD60-45F4-B258-24E3C5C8244F
wdt:P2888
n11:s00432-011-1095-9
p:P2860
wds:Q50990782-0555454D-5492-4C44-8C78-74620780F027 wds:Q50990782-069751D8-13CC-4689-ABBD-329E6B14C2A0 wds:Q50990782-07F0F3CF-7034-423A-8A05-C84FA0ECEA65 wds:Q50990782-0A239186-2BDE-46C3-9576-472A767AD468 wds:Q50990782-169A2CC4-AFAB-4FD4-A398-99946461DB19 wds:Q50990782-39E2E6BF-5701-48ED-BBA4-709D3757B9BE wds:Q50990782-3C29B80C-1FFC-4C60-8459-6123499661D5 wds:Q50990782-4BCA1203-7188-483B-B6B2-E3DB29464708 wds:Q50990782-4C53A1BF-82FC-408A-A7AE-860FF60C287A wds:Q50990782-58F67590-DCA6-4483-B691-FAC7395705B5 wds:Q50990782-17A6CB39-F655-48B3-A254-AF2B84ADA7D9 wds:Q50990782-1DA3FF4B-7916-490D-8CED-DBA42661AAB0 wds:Q50990782-1E3C94B7-A16D-41CD-8542-1B2C1560076C wds:Q50990782-1F0BD3EB-2CB8-439C-A828-07FE099B24C9 wds:Q50990782-205B51BE-B684-4FA9-A41B-2184720DCD53 wds:Q50990782-222B3C24-8452-4D61-A101-D25EA69D16C3 wds:Q50990782-7EF690BA-16E5-407C-AE57-503BC534611B wds:Q50990782-832CA966-055B-4E74-B5A5-1345769268A7 wds:Q50990782-868D84C5-E8CA-4715-9B44-F4317473F530 wds:Q50990782-88A60388-DD6F-44E8-9871-F98DAA0063E8 wds:Q50990782-8DA934F9-F9C3-44B3-88D8-0171D64AFB17 wds:Q50990782-8ED37411-CB31-4509-828D-678B81BF821C wds:Q50990782-5AE2FD57-AE2D-409A-8AE3-17258753338A wds:Q50990782-60A6504F-EF09-4FEF-9740-037BE998C487 wds:Q50990782-6E52CD6E-698F-4312-BD59-E5F0E255B0F0 wds:Q50990782-716F8ED8-B72E-4190-B74D-613CF356FF99 wds:Q50990782-74454F01-C827-4281-971A-F60918E27122 wds:Q50990782-BC1838F2-274E-4CF6-849E-742917D5F199 wds:Q50990782-C4F48417-B84B-4AFE-B8C7-6F7E0BE55E27 wds:Q50990782-91126014-2CCF-4F6A-8528-4F75DB153864 wds:Q50990782-944C38E0-BA87-4CD8-A24B-6F4E44355741 wds:Q50990782-948AF027-24BD-4577-B1A5-4C94742E5BAF wds:Q50990782-9C475198-8382-41E4-8A11-090930725019 wds:Q50990782-A8F0E92B-01A0-4180-BA7E-AED248C9C713 wds:Q50990782-AF26D842-B048-42C3-9685-43F8C0FEF1D5 wds:Q50990782-E13B7119-6573-4481-9515-DEE56E715B99 wds:Q50990782-E5C96C1F-F198-48BA-9094-845FB4AE2A5B wds:Q50990782-EBEA0BBB-1595-41E9-B5F2-45001A64261C wds:Q50990782-D56AE7F6-50AF-41C5-94D0-5BD2565AECE1 wds:Q50990782-D5FCCD3F-D0F2-46AF-B5AA-86EF0338EC63 wds:Q50990782-D6D542C5-0328-491B-8860-1F122C2F1CCC wds:Q50990782-DA1F4EEE-A4F4-45D0-BF52-92711351B056 wds:Q50990782-DACDFA13-6B73-41E8-ACEB-33F374D41197 wds:Q50990782-DD5E25EF-0D84-4DE1-A2F1-9EE8065D0956
wdt:P2860
wd:Q71127378 wd:Q53978084 wd:Q71692738 wd:Q77331953 wd:Q72682030 wd:Q47969106 wd:Q40630247 wd:Q73559928 wd:Q77626790 wd:Q35769870 wd:Q83897290 wd:Q83978585 wd:Q53394493 wd:Q72673347 wd:Q74036838 wd:Q37405169 wd:Q74218277 wd:Q27824847 wd:Q29617440 wd:Q54688145 wd:Q79766236 wd:Q61853738 wd:Q79228390 wd:Q44832181 wd:Q79157507 wd:Q72493574 wd:Q27860693 wd:Q81704698 wd:Q75200979 wd:Q43918766 wd:Q46813842 wd:Q73393172 wd:Q78200965 wd:Q29616112 wd:Q72230737 wd:Q53243856 wd:Q33794421 wd:Q36686976 wd:Q79409162 wd:Q84152073 wd:Q74239122 wd:Q38474138 wd:Q57274847 wd:Q44079703
p:P2093
wds:Q50990782-E2C6642E-31A4-4154-9592-1E340E936A60 wds:Q50990782-D79404A8-F15C-41A2-B437-A0DE781C0C85 wds:Q50990782-D55E0883-9341-4992-88A4-1CEEC3C23762 wds:Q50990782-C65771CE-56FC-4EB8-BDDC-EFA9BE85ABF1 wds:Q50990782-BCECC23A-AA32-4346-A6B2-95AE5F3789AB wds:Q50990782-B84FA869-C2C9-4E89-B0B9-C1CB8BB4DE68 wds:Q50990782-89B5E026-F530-459D-98D0-A3E9BAB528C7 wds:Q50990782-65292062-3DA9-476D-91F7-61D6E4BF04F2 wds:Q50990782-5858ACBD-2320-4DF3-95AF-DBB08C49E261 wds:Q50990782-43FCB9C0-F0DE-4218-AFE6-0F8639B57F70 wds:Q50990782-34BFE599-0781-4405-8468-229D927F5A7F wds:Q50990782-0666E24F-06CD-44B5-86DB-91D1C83900B2
wdt:P2093
Laisheng Li Weidong Wei Xinhua Xie Xiangsheng Xiao Jiaoli Guo Shuqin Dai Ning Lv Weihua Jia Yanan Kong Wanli Liu Xiaoming Xie Yin Zhang
rdfs:label
High serum HER2 extracellular domain levels: correlation with a worse disease-free survival and overall survival in primary operable breast cancer patients. High serum HER2 extracellular domain levels: correlation with a worse disease-free survival and overall survival in primary operable breast cancer patients.
skos:prefLabel
High serum HER2 extracellular domain levels: correlation with a worse disease-free survival and overall survival in primary operable breast cancer patients. High serum HER2 extracellular domain levels: correlation with a worse disease-free survival and overall survival in primary operable breast cancer patients.
schema:name
High serum HER2 extracellular domain levels: correlation with a worse disease-free survival and overall survival in primary operable breast cancer patients. High serum HER2 extracellular domain levels: correlation with a worse disease-free survival and overall survival in primary operable breast cancer patients.
p:P50
wds:Q50990782-06718F28-30BF-4EDB-BCEB-9B4572CB8D4F
wdt:P50
wd:Q57023118
p:P1476
wds:Q50990782-88F6B089-FCD1-445E-9DB1-F72EB000DF56
wdt:P1476
High serum HER2 extracellular domain levels: correlation with a worse disease-free survival and overall survival in primary operable breast cancer patients.
p:P304
wds:Q50990782-02528C1E-32AD-4DE7-A189-56DE905BA8E3
wdt:P304
275-284
p:P31
wds:Q50990782-4A2ED666-AA8D-4F7C-BC1E-62464F41353B
wdt:P31
wd:Q13442814
p:P698
wds:Q50990782-7B9514D4-29E1-43AA-B8A4-062C35DB7383
wdtn:P698
n9:22116318
wdt:P698
22116318
p:P1433
wds:Q50990782-D414D0D7-A6A8-41DF-8916-51E1979AAD10
wdt:P1433
wd:Q2081599
p:P433
wds:Q50990782-BF06BF97-3EDD-492C-ADC0-E848E7A7A753
p:P478
wds:Q50990782-B4DE43A0-BB3E-4791-99F8-5E26EFCEB32F
wdt:P433
2
wdt:P478
138
p:P356
wds:Q50990782-7E492F2C-BF16-477B-BD32-DABA144E844B
wdtn:P356
n12:S00432-011-1095-9
wdt:P356
10.1007/S00432-011-1095-9
p:P8608
wds:Q50990782-978CB580-C29D-4ACF-8878-43EF21A834B8
wdt:P8608
release_sjjocajbgrdhtbbcwfb36pr6t4